PMVP FY 2025 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$86M

Net Income

-$78M

EPS (Diluted)

$-1.48

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$74M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$117M

Total Liabilities

$12M

Stockholders' Equity

$105M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$86M	-$85M	-0.9%
Net Income	-$78M	-$59M	-32.4%